We are live on ! Find out more
BIMI

BIMI International Medical Inc. Common Stock

Delisted

BIMI was delisted on the 21st of August, 2024.

8 hedge funds and large institutions have $677K invested in BIMI International Medical Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

19% more capital invested

Capital invested by funds: $570K → $677K (+$107K)

0% more funds holding

Funds holding: 88 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BIMI Hedge Fund Activity: Q2 2021 in Review

8 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q2 2021, worth a combined $677K — up 19% from $570K a quarter earlier.

Fund positioning in BIMI was balanced in Q2 2021: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $309K. The largest seller was Citadel Advisors, cutting an estimated $180K.

  • 8 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $677K of BIMI International Medical Inc. Common Stock stock for Q2 2021, up 19% quarter-over-quarter.
  • 4 funds opened new BIMI International Medical Inc. Common Stock positions in Q2 2021 and 4 closed out, a net change of 0 holders.
  • The largest BIMI International Medical Inc. Common Stock buyer in Q2 2021 was Renaissance Technologies, an estimated $309K added.
  • The largest BIMI International Medical Inc. Common Stock seller in Q2 2021 was Citadel Advisors, an estimated $180K sold.

Based on aggregated 13F filings for Q2 2021.